Serum Magnesium Levels in Pediatric Inpatients: A Study in Laboratory Overuse
Increases in health care spending continue to be a major area of concern among health policy experts, and the current trajectory of spending has been described as unsustainable, 1 with estimates placing health care at 20% of the gross domestic product by 2020. The overtreatment of patients, which includes unnecessary laboratory evaluations, has been estimated to be responsible for up to $226 billion of wasted health care money in 2011 alone. The overuse of laboratory resources is one such area in which quality improvement interventions can help reduce costs. www.hospitalpediatrics.org 60% incidence of hypomagnesemia on arrival but are divided on its role in predicting mortality and length of ICU stay. [4] [5] [6] Outside of the ICU, hypomagnesemia has been reported in children with malignancy 7 and in up to 15% of those being treated for malnutrition, 8 but its role as a routine laboratory assessment has not been studied.
The goal of the present study was to investigate the ordering of serum Mg levels to determine the necessity of such testing and the potential fi nancial impact of its overuse. Based on our observations, we hypothesized that the vast majority of Mg levels ordered on non-ICU patients are not clinically meaningful and result in unnecessary laboratory utilization. We also sought to identify diagnoses most commonly associated with abnor mal Mg levels at an individual institution to help target cost-effective ordering practices.
METHODS
This study was a cross-sectional mixed methods study using Pediatric Health Information Systems (PHIS) database (Children's Hospital Association, Overland Park, KS) data as well as a chart review of local data. The PHIS database contains de-identifi ed administrative data, detailing demographic characteristics, diagnostics, procedures, and pharmacy billing, from 43 freestanding tertiary care children's hospitals. This database accounts for ∼20% of all annual pediatric hospitalizations in the United States. Data quality is ensured through a joint effort between the Children's Hospital Association and participating hospitals. 9 All 43 PHIS hospitals were represented in the present study.
Inclusion criteria were all children aged 0 to 18 years, admitted in the years 2010 through 2011, with laboratory charges for serum Mg levels. Patients with ICU-level charges were excluded. PHIS data were used to compare Mg ordering practices among similar academic centers. Chart review of local data obtained through PHIS was used to identify both the frequency of clinically meaningful Mg levels and associated diagnoses.
A clinically meaningful Mg level was defi ned as any result that was followed by an intervention. We defi ned these interventions as orders for either a new Mg supplement or a modifi cation of an existing Mg supplement, including changes to Mg concentration in total parenteral nutrition (TPN). Patients receiving TPN were included to assess the need for routine Mg-level monitoring for those with consistent electrolyte concentrations. We excluded orders for Mg sulfate for asthma, orders for Mg salts for constipation, and orders for home medications as determined by nursing intake medication reconciliation, unless any of these were preceded by a low Mg level as defi ned according to reference values. Timing of these interventions varied from within 60 minutes to within 24 hours (in the case of modifying TPN electrolyte concentrations).
National Data Extraction
Aggregate data were extracted from each PHIS institution, including case mix index (CMI) for all patients and for patients with Mg laboratory charges, total patient-days for patients with Mg laboratory charges, total Mg laboratory and supplement charges, and percentage of all cases with Mg laboratory charges. We excluded any patients with ICU charges.
Medians and interquartile ranges were calculated for percentage of patients with Mg laboratory charges and for Mg laboratory charges per patientday at each PHIS institution. To determine the relationship between patient com plexity and Mg utilization, we performed a goodness-of-fi t analysis with mean institutional CMI as our independent variable. Using Microsoft Excel (Microsoft Corporation, Redmond, WA), the coeffi cient of determination value was calculated between CMI and the following: (1) the percentage of patients with Mg laboratory char ges at each institution; and (2) Mg supplement charges per patient, as a proxy for frequency of intervention for clinically meaningful Mg levels.
Local Data Extraction
De-encrypted medical record numbers were obtained from PHIS for patients with Mg laboratory charges at our institution, and we performed manual chart reviews on the subset of patients with both Mg laboratory charges and Mg supplement charges. Data were collected on discharge diagnoses, number of Mg levels ordered, timing of Mg level orders, actual serum Mg levels, types of Mg supplements ordered (including TPN), timing of Mg supplement orders, and concentrations of Mg in TPN orders. Appendix 1 presents the reference laboratory values at our institution.
RESULTS
Over the 2-year study period, 823 696 non-ICU inpatient cases were identifi ed; 16.4% (135 085) had Mg laboratory charges. Total laboratory charges over the study period equaled $41 million. Patients with Mg laboratory charges had higher mean CMI (2.2 vs 0.9) and longer mean length of stay (7.4 vs 3. Our study identifi ed 367 patients receiving TPN at our institution who had Mg laboratory charges; 80% of these patients (n = 295) had all Mg levels within the normal reference range. Seventy-nine patients (22%) had interventions for their levels, including 32 with levels within normal reference range; 78 of these patients were in 1 of the 4 major diagnosis categories listed earlier.
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12 | VOLUME 5 • ISSUE 1 www.hospitalpediatrics.org There were 13 cases of hypermagnesemia (range: 2.3-2.8 mg/dL) that led to interventions; 11 were associated with TPN, and 10 were in 1 of the 4 major diagnosis categories de scribed earlier. The remaining 3 cases were as follows: (1) a 9-year-old with chronic pancreatitis who had Mg levels in TPN adjusted after a level of 2.6 mg/dL was recorded; (2) a 16-year-old with infl ammatory bowel disease who received Mg citrate for bowel preparation before a colonoscopy and had Mg levels in TPN adjusted after a level of 2.4 mg/dL was recorded; and (3) a 14-yearold with status asthmaticus and aortic stenosis who received intravenous furosemide after a dose of intravenous Mg sulfate (peak level: 2.7 mg/dL).
We also identifi ed 68 patients at our institution with a discharge diagnosis of asthma who had both an Mg sulfate supplement charge and an Mg laboratory charge. Twenty-three (34%) patients had a high Mg level (range: 2.3-2.8 mg/dL), but only 1 patient (discussed earlier) received treatment. We also reviewed charts for patients admitted with 4 common pediatric diagnoses (asthma, pneumonia, bronchiolitis, and cellulitis) and found a very low overall incidence of clinically meaningful Mg levels (Table 3) .
DISCUSSION
Our study found that the majority of Mg levels ordered in non-ICU pediatric inpatients at our institution did not require intervention. Individual PHIS hospitals exhibited wide variations in frequency of Mg laboratory ordering, raising the question of whether the level of care provided can be just as effective with decreased laboratory usage. Across all PHIS hospitals, there was an association between patients' CMI and Mg laboratory charges, but data at our institution suggest that the majority of Mg laboratory charges are still ordered for conditions with low incidence of hypomagnesemia or hypermagnesemia. Clinically meaningful Mg levels were clustered in 4 major disease categories, all of which carry high medical complexity. We also found that those patients with clinically meaningful Mg levels only accounted for 16% of the total Mg laboratory charges at our institution. The remaining levels represented $1.6 million in total charges over the study period, many of which may not have been necessary.
Kaplinsky and Alon 7 previously described the link between chemotherapy and hypomagnesemia, and we found a high incidence in children undergoing bone marrow transplant, stem cell transplant, and treatment of osteosarcoma. Many of these regimens included cisplatin, which has been linked to renal Mg wasting in children and adults. 10, 11 We also found several cases of abnormal Mg levels in children with a history of solid organ transplant, which had previously been reported by Staatz et al 12 and Al-Rasheed et al 13 in association with tacrolimus and cyclosporine, respectively. Many solid organ transplant patients in our study had hypomagnesemia on admission and required intravenous Mg sulfate boluses. Similarly, intestinal failure and short bowel syndrome seemed to predispose children to abnormal Mg levels, which has previously only been described in case reports of adults. 14, 15 Our data, in conjunction with previous research, suggest routine assessment of Mg levels for children hospitalized for chemotherapy or with a history of a bone marrow or solid transplant, conditions which likely do not represent overuse.
In contrast to previous research, 8 we found no cases of hypomagnesemia in patients with eating disorders or protein-calorie malnutrition. We identified 26 patients aged ≥10 years with Diagnosis-Related Group codes for malnutrition or eating disorders. These patients had 190 Mg laboratory charges totaling $24 000; all of the tested levels were in the normal reference range for age. Three patients were started on TPN during their hospitalization, and none received other oral or intravenous Mg supplements. The role of Mg-level monitoring in children receiving TPN has not been thoroughly studied. We found abnormal Mg levels in patients receiving TPN specifi cally after abdom inal surgery, as opposed to consistently normal levels in patients receiving TPN for nonsurgical illnesses such as 16 who found a 28% incidence of adults with the disease. Baker et al 17 re ported that most TPN-associated hypomagnesemia was present before initiation of TPN, and our subanalysis found a low incidence of Mg abnormalities with TPN, in addition to the 4 diagnosis groups previously listed. Ali et al 18 described 2 cases of iatrogenic hypermagnesemia after pharmacy errors, but no other such associations have been reported. Hypermagnesemia has also been reported in patients taking oral Mg oxide, but these levels do not require intervention. 19, 20 In our study population, some of whom took daily Mg supplements at home, the highest Mg level found was 2.8 mg/dL; symptoms usually do not appear until the serum Mg level is >4.5 mg/dL.
The only pediatric case reports of lifethreatening hypermagnesemia have been in patients receiving excessive doses of Mg supplements [21] [22] [23] [24] or with late-stage chronic kidney disease. 25 Based on our data and literature review, the yield of Mg levels in patients taking oral Mg supplements seems low outside of the 4 major diagnosis categories (oncologic, short bowel, solid organ transplant, and abdominal surgery requiring TPN).
To our knowledge, the present study is the only trial specifi c to Mg-level ordering practices in pediatrics; however, the issue of unnecessary diagnostic and laboratory evaluations has been well documented in medical literature, especially at academic centers similar to ours. 26, 27 Our study identifi ed an example of laboratory overuse that lends itself to efforts for quality improvement, such as using audits to change existing behaviors. [28] [29] [30] A systematic review by Jamtvedt et al 28 demonstrated varying degrees of effectiveness of such techniques in achieving change. Interventions tended to be more effective with more aggressive feedback regimens and if compliance with the desired behavior is low at the start of an intervention. Our fi nding of a limited set of diagnoses associated with hypomagnesemia could be used as a feedback intervention to help target Mg laboratory ordering practices.
Administrative solutions have also been used successfully in decreasing laboratory overutilization. Providing physicians with the price of laboratory tests at time of ordering has been shown to reduce costs in a pediatric ED setting, 31 but results have been inconsistent overall. 32 In addition, computerized provider order entry can be used to restrict a provider's ability to order laboratory tests. 32, 33 Since the completion and analysis of these data, our institution has removed serum Mg levels from most general pediatric admission order sets in an attempt to eliminate indiscriminate ordering.
There are several limitations to the present study. Although we were able to obtain charge data, the true reduction in cost from eliminating all unnecessary Mg studies is unclear. We recognize that the marginal cost of Mg testing may be insignifi cant compared with the total hospital stay, but bringing continued awareness to the issue of resource overuse could lead to future, more substantial reductions in fi xed cost, as suggested by Auerbach and Wachter. 34 We were only able to analyze patientlevel data at 1 institution; the PHIS database as used in the present Future directions for this project should involve the aforementioned quality improvement methods as well as the development of an educational module by using dissemination and implementation (D&I) methods. D&I is an emerging multidisciplinary science that investigates integration of evidencebased interventions into practice settings, as well as the process of spreading knowledge and information to these settings. A D&I follow-up project would pinpoint behavioral drivers of laboratory overuse and build an effective intervention for a pre-/ post-analysis.
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CONCLUSIONS
At our institution, serum Mg levels were frequently ordered in non-ICU inpatients who never required intervention for the resulting levels. This fi nding represented charges of $1.6 million from 2010 through 2011. Most clinically meaningful Mg levels were found in select subsets of patients. At individual children's hospitals, there was no correlation between patient complexity and the frequency of Mg laboratory ordering. Future directions of study to discourage laboratory overuse include education of medical staff by using a D&I approach and the use of diagnosis-specifi c admission order sets to facilitate focused ordering of Mg levels. 
